APA

Guilhamon P., Butcher L. M., Presneau N., Wilson G. A., Feber A., Paul D. S., Schütte M., Haybaeck J., Keilholz U., Hoffman J., Ross M. T., Flanagan A. M. & Beck S. (20150114). Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics. : Genome medicine.

Chicago

Guilhamon Paul, Butcher Lee M, Presneau Nadege, Wilson Gareth A, Feber Andrew, Paul Dirk S, Schütte Moritz, Haybaeck Johannes, Keilholz Ulrich, Hoffman Jens, Ross Mark T, Flanagan Adrienne M and Beck Stephan. 20150114. Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics. : Genome medicine.

Harvard

Guilhamon P., Butcher L. M., Presneau N., Wilson G. A., Feber A., Paul D. S., Schütte M., Haybaeck J., Keilholz U., Hoffman J., Ross M. T., Flanagan A. M. and Beck S. (20150114). Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics. : Genome medicine.

MLA

Guilhamon Paul, Butcher Lee M, Presneau Nadege, Wilson Gareth A, Feber Andrew, Paul Dirk S, Schütte Moritz, Haybaeck Johannes, Keilholz Ulrich, Hoffman Jens, Ross Mark T, Flanagan Adrienne M and Beck Stephan. Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics. : Genome medicine. 20150114.